TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Queue the 2018 Rebound for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be slated to enjoy a huge 2018. Here's why investors may want to back…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals International Inc. Is Trading at 52-Week Highs: Should You Buy or Sell?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is still in early stages of a comeback, with many hurdles to overcome.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Recent Debt Offering a Genius Move

    By refinancing $1.5 billion of debt due in 2020, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) CEO Joe Papa has continued to impress…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Surges ~12% in a Day: Why the Stock Could Easily Double in 2018

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) surged along with the biotech and pharma industry. Here's why investors should expect more big…

    Read more »

    Dividend Stocks

    New to Investing? Avoid These 5 “Rookie” Mistakes

    Follow these five tips that will help you avoid common pitfalls of investing in stocks such as Valeant Pharmaceuticals Intl…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Best Long-Term Rebound Play on the TSX?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) looks like it's on the road to a rebound. Here's why investors may want to…

    Read more »

    Investing

    Aurora Cannabis Inc. Surges ~153% in a Month: Can it Catch Up to Canopy Growth Corp.?

    Are Aurora Cannabis Inc. (TSX:ACB) shares too hot to handle at current levels? Or is the company going after Canopy…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: If You’d Bought the Dip, You’re up

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has had a great month, and it could continue to ride that wave.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Opportunity or Value Trap?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has shown signs of improvement under Joseph Papa. Should investors take a risk on the…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is on the Path to Recovery

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) soared 17% on November 7 after the release of strong Q3 results and keeps rising.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Gives Back Controversial New Drug

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced this week the sale of the controversial female-libido-enhancing drug Addyi.

    Read more »

    Investing

    Why Canada Goose Holdings Inc.’s Strong Q2 Shouldn’t Convince You to Buy the Stock

    Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) had a very strong second quarter, but there are still some concerns investors should have about…

    Read more »